4.7 Article

Expert consensus document from the European Society of Cardiology on catheter-based renal denervation

Journal

EUROPEAN HEART JOURNAL
Volume 34, Issue 28, Pages 2149-2157

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/eurheartj/eht154

Keywords

-

Funding

  1. Deutsche Hochdruckliga
  2. Deutsche Forschungsgemeinschaft
  3. Deutsche Gesellschaft fur Kardiologie
  4. Abbott
  5. Biotronik
  6. Biosensors
  7. Boston Scientific
  8. Cordis
  9. Medtronic
  10. St Jude
  11. Edwards Lifesciences
  12. Medtronic-Ardian
  13. Recor
  14. Medical Research Council [MC_PC_13090] Funding Source: researchfish
  15. National Institute for Health Research [NF-SI-0509-10222] Funding Source: researchfish
  16. MRC [MC_PC_13090] Funding Source: UKRI

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Peripheral Vascular Disease

Sex Differences in Blood Pressure and Potential Implications for Cardiovascular Risk Management

Dean S. Picone, Elif Stoneman, Antoine Cremer, Martin G. Schultz, Petr Otahal, Alun D. Hughes, J. Andrew Black, Willem Jan Bos, Chen-Huan Chen, Hao-Min Cheng, Nathan Dwyer, Peter Lacy, Esben Laugesen, Fuyou Liang, Hack-Lyoung Kim, Nobuyuki Ohte, Sho Okada, Stefano Omboni, Christian Ott, Telmo Pereira, Giacomo Pucci, Ronak Rajani, Roland Schmieder, Manish D. Sinha, Ralph Stewart, George A. Stouffer, Kenji Takazawa, Jiguang Wang, Thomas Weber, Berend E. Westerhof, Bryan Williams, Hirotsugu Yamada, James E. Sharman

Summary: Accurate blood pressure measurement is crucial for cardiovascular risk management. A study found that for the same cuff systolic blood pressure, women had higher invasive aortic systolic blood pressure than men. Cuff measurements may underestimate cardiovascular risk in women.

HYPERTENSION (2023)

Review Cardiac & Cardiovascular Systems

Addressing global disparities in blood pressure control: perspectives of the International Society of Hypertension

Aletta E. Schutte, Tazeen H. Jafar, Neil R. Poulter, Albertino Damasceno, Nadia A. Khan, Peter M. Nilsson, Jafar Alsaid, Dinesh Neupane, Kazuomi Kario, Hind Beheiry, Sofie Brouwers, Dylan Burger, Fadi J. Charchar, Myeong Chan Cho, Tomasz J. Guzik, Ghazi F. Haji Al-Saedi, Muhammad Ishaq, Hiroshi Itoh, Erika S. W. Jones, Taskeen Khan, Yoshihiro Kokubo, Praew Kotruchin, Elizabeth Muxfeldt, Augustine Odili, Mansi Patil, Udaya Ralapanawa, Cesar A. Romero, Markus P. Schlaich, Abdulla Shehab, Ching Siew Mooi, U. Muscha Steckelings, George Stergiou, Rhian M. Touyz, Thomas Unger, Richard D. Wainford, Ji-Guang Wang, Bryan Williams, Brandi M. Wynne, Maciej Tomaszewski

Summary: Hypertension is the leading cause of preventable death globally, but there are significant challenges in its detection, treatment, and control, particularly in low-resource settings. Disparities based on resources, sociodemographic environment, and race contribute to the disproportionate burden of hypertension-related outcomes. Immediate action is needed to address these challenges and reduce inequities in hypertension care.

CARDIOVASCULAR RESEARCH (2023)

Review Cardiac & Cardiovascular Systems

Predictive value of post-percutaneous coronary intervention fractional flow reserve: a systematic review and meta-analysis

Birgitte Krogsgaard Andersen, Daixin Ding, Lone Juul Hune Mogensen, Shengxian Tu, Niels Ramsing Holm, Jelmer Westra, William Wijns

Summary: This systematic review and study-level meta-analysis investigated the relationship between post-PCI FFR and the rate of major adverse cardiac events (MACE) including all-cause death, myocardial infarction (MI), and target vessel revascularization (TVR). The results showed no clear continuous association between post-PCI FFR and clinical outcomes, but in studies comparing high vs. low post-PCI FFR, high FFR was associated with better clinical outcomes.

EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES (2023)

Article Cardiac & Cardiovascular Systems

Prediction of conduction disturbances in patients undergoing transcatheter aortic valve replacement

Valerie Pavlicek, Felix Mahfoud, Katharina Bubel, Peter Fries, Sebastian Ewen, Michael Boehm, Bruno Scheller, Christian Ukena

Summary: The aim of this study was to investigate clinical, anatomical, procedural, and electrophysiological parameters predicting intraventricular conduction disturbances (ICA) after transcatheter aortic valve replacement (TAVR). The results showed that new-onset left bundle branch block (BBB) and diabetes mellitus independently predicted high-degree atrioventricular block (HAVB) requiring permanent pacemaker (PPM) implantation, and helped identify high-risk patients.

CLINICAL RESEARCH IN CARDIOLOGY (2023)

Editorial Material Cardiac & Cardiovascular Systems

Benefits of SGLT2i in heart failure across a broad range of ejection fractions: new opportunities and future challenges

Massimo Volpe, Carlo Patrono

EUROPEAN HEART JOURNAL (2023)

Review Cardiac & Cardiovascular Systems

Endocrine functions of the heart: from bench to bedside

Massimo Volpe, Giovanna Gallo, Speranza Rubattu

Summary: The heart has an endocrine function, producing biologically active substances such as natriuretic peptides (NPs). NPs play important roles in regulating cardiovascular and renal systems through their interaction with guanylate cyclase-A coupled receptors. They also have potential therapeutic applications in treating heart failure and hypertension, and are used as biomarkers in cardiovascular diseases. Furthermore, research on the regulation of NP synthesis and secretion by microRNAs and epigenetics, as well as their interactions with other endocrine systems, is ongoing.

EUROPEAN HEART JOURNAL (2023)

Editorial Material Cardiac & Cardiovascular Systems

High-Intensity Lipid-Lowering Therapies: An Opportunity for Improving Cardiovascular Outcomes in Postmenopausal Women?

Martine Gilard, William Wijns

CIRCULATION-CARDIOVASCULAR IMAGING (2023)

Article Cardiac & Cardiovascular Systems

Management strategies for heavily calcified coronary stenoses: an EAPCI clinical consensus statement in collaboration with the EURO4C-PCR group

Emanuele Barbato, Emanuele Gallinoro, Mohamed Abdel-Wahab, Daniele Andreini, Didier Carrie, Carlo Di Mario, Dariusz Dudek, Javier Escaned, Jean Fajadet, Giulio Guagliumi, Jonathan Hill, Margaret McEntegart, Kambis Mashayekhi, Nikolasos Mezilis, Yoshinobu Onuma, Krzyszstof Reczuch, Richard Shlofmitz, Giulio Stefanini, Giuseppe Tarantini, Gabor G. Toth, Beatriz Vaquerizo, William Wijns, Flavio L. Ribichini

Summary: Since the publication of the 2015 EAPCI consensus, there has been a significant increase in PCI performed in cases of severely calcified coronary artery disease. This has been driven by the growing need for interventions in elderly patients and the availability of new technologies. The current EAPCI clinical consensus statement provides comprehensive guidance on the management of heavily calcified coronary stenoses, including imaging assessment, tool and technique selection, and considerations for complications and training.

EUROPEAN HEART JOURNAL (2023)

Review Cardiac & Cardiovascular Systems

Interventional therapies for pulmonary embolism

Felix Goetzinger, Lucas Lauder, Andrew S. P. Sharp, Irene M. Lang, Stephan Rosenkranz, Stavros Konstantinides, Elazer R. R. Edelman, Michael Boehm, Wissam Jaber, Felix Mahfoud

Summary: Pulmonary embolism (PE) is a major cause of in-hospital and cardiovascular death. The treatment of PE traditionally involved anticoagulation, thrombolysis, or surgery, but newer percutaneous interventional technologies have emerged for intermediate-high-risk or high-risk PE patients. This review discusses the pathophysiology of PE, assists with patient selection, and evaluates the clinical evidence for interventional, catheter-based approaches for PE treatment.

NATURE REVIEWS CARDIOLOGY (2023)

Editorial Material Cardiac & Cardiovascular Systems

Artificial intelligence in echocardiography: a better alternative to the human eye?

Leonarda Galiuto, Massimo Volpe

EUROPEAN HEART JOURNAL (2023)

Editorial Material Cardiac & Cardiovascular Systems

Atrial fibrillation ablation improves outcomes in patients with end-stage heart failure: is it all gold the glitter in the CASTLE?

Daniela Pedicino, Massimo Volpe

EUROPEAN HEART JOURNAL (2023)

Article Cardiac & Cardiovascular Systems

Acquired cardiovascular disease in adults with congenital heart disease

Margarita Brida, Salvatore De Rosa, Antoine Legendre, Magalie Ladouceur, Laura Dos Subira, Giancarlo Scognamiglio, Carlo Di Mario, Jolien Roos-Hesselink, Eva Goossens, Gerhard Diller, Michael A. Gatzoulis

Summary: The rates of successful surgical repair and life expectancy for patients with congenital heart disease have significantly increased in recent decades. However, exposure to cardiovascular risk factors has led to a shift in the clinical trajectory of adult congenital heart disease, with an increasing burden of acquired cardiovascular disease, primarily atherosclerotic cardiovascular disease (ASCVD). Currently, comprehensive guidance for the prevention and management of acquired heart disease in adult congenital heart disease patients is lacking. This document provides an overview of acquired heart disease and offers guidance on ASCVD prevention for both specialists and non-specialists in adult congenital heart disease, aiming to reduce the cardiovascular burden in this growing population.

EUROPEAN HEART JOURNAL (2023)

Article Cardiac & Cardiovascular Systems

Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

Emanuele Barbato, Michel Azizi, Roland E. Schmieder, Lucas Lauder, Michael Boehm, Sofie Brouwers, Rosa Maria Bruno, Dariusz Dudek, Thomas Kahan, David E. Kandzari, Thomas F. Luescher, Gianfranco Parati, Atul Pathak, Flavio L. Ribichini, Markus P. Schlaich, Andrew S. P. Sharp, Isabella Sudano, Massimo Volpe, Costas Tsioufis, William Wijns, Felix Mahfoud

Summary: According to the 2018 ESC/ESH guidelines, radiofrequency and ultrasound renal denervation (RDN) have been proven effective and safe in lowering blood pressure in a broad range of patients with hypertension, including resistant hypertension. The expert group suggests that RDN can be used as an adjunct treatment option in uncontrolled resistant hypertension, especially in patients with high cardiovascular risk or hypertension-mediated organ damage. Multidisciplinary hypertension teams should evaluate the indication and perform the RDN procedure.

EUROINTERVENTION (2023)

Meeting Abstract Peripheral Vascular Disease

ANTIHYPERTENSIVE TREATMENT IMPROVES LEFT VENTRICULAR DIASTOLIC FUNCTION AND INDICES OF ARTERIAL STIFFNESS IN YOUNGER MEN WITH GRADE 1 HYPERTENSION

Dawid Jedrzejewski, Ewan McFarlane, Peter Lacy, Bryan Williams

JOURNAL OF HYPERTENSION (2023)

Article Cardiac & Cardiovascular Systems

Real-world experience with ultrasound renal denervation utilizing home blood pressure monitoring: the Global Paradise System registry study design

Felix Mahfoud, Michel Azizi, Joost Daemen, Andrew S. P. Sharp, Atul Patak, Juan F. Iglesias, Ajay Kirtane, Naomi D. L. Fisher, Andrea Scicli, Melvin D. Lobo

Summary: This study aims to investigate the long-term safety and effectiveness of ultrasound renal denervation (uRDN) with the Paradise System in a large population of hypertensive patients. It will provide real-world information and patient-reported outcomes through home blood pressure measurements and routine clinical follow-up.

CLINICAL RESEARCH IN CARDIOLOGY (2023)

No Data Available